Table: begin end state 1 20 cytoplasmic 21 43 transmembrane 44 51 non-cytoplasmic 52 74 transmembrane 75 102 cytoplasmic 103 125 transmembrane 126 130 non-cytoplasmic 131 149 transmembrane 150 160 cytoplasmic 161 182 transmembrane 183 200 non-cytoplasmic 201 224 transmembrane 225 244 cytoplasmic 245 266 transmembrane 267 286 non-cytoplasmic 287 312 transmembrane 313 347 cytoplasmic 348 365 transmembrane 366 370 non-cytoplasmic 371 394 transmembrane 395 414 cytoplasmic 415 435 transmembrane 436 446 non-cytoplasmic 447 467 transmembrane 468 489 cytoplasmic
Input: >BWI76_RS19685 MVSDTKTTEAPGLRRELKARHLTMIAIGGSIGTGLFVASGATISQAGPGGALLSYILIGL MVYFLMTSLGELAAFMPVSGSFATYGQNYVEEGFGFALGWNYWYNWAVTIAVDLVAAQLV MTYWFPDAPGWVWSALFLGIMFLLNWISVKGFGEAEYWFSLIKVATVIIFIIVGVMMIFG IFKGAQPAGWSNWVIDDAPFAGGFAAMIGVAMIVGFSFQGTELIGIAAGESENPEKNIPR AVRQVFWRILLFYVFAILIISLIIPYTDPSLLRNDVKDISVSPFTLVFQHAGLLSAAAIM NAVILTAVLSAGNSGMYASTRMLYTLACDGKAPRIFSKLSKGGVPRNALYATTVIAGLCF LSSMFGNQTVYLWLLNTSGMTGFIAWLGIAISHYRFRRGYVLQGNDLNDLPYRSGFFPLG PIFAFVLCLIITLGQNYEAFLKDTIDWGGVAATYIGIPLFLVIWFGYKLAKGTRFVRYSE MKFPERFKG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server